Domain Partners VIII, L.P.'s Net Worth
$210 Million
Who is Domain Partners VIII, L.P.?
Domain Partners VIII, L.P. has an estimated net worth of $210 Million. This is based on reported shares across multiple companies, which include OTONOMY, INC., Dicerna Pharmaceuticals Inc, Bionano Genomics, Inc., GLAUKOS Corp, VERACYTE, INC., Atara Biotherapeutics, Inc., Syndax Pharmaceuticals Inc, Alliqua BioMedical, Inc., aTYR PHARMA INC, Durata Therapeutics, Inc., ACHILLION PHARMACEUTICALS INC, and Ocera Therapeutics, Inc..
SEC CIK
Domain Partners VIII, L.P.'s CIK is 0001465144
Past Insider Trading and Trends
2014 was Domain Partners VIII, L.P.'s most active year for acquiring shares with 6 total transactions. Domain Partners VIII, L.P.'s most active month to acquire stocks was the month of July. 2014 was Domain Partners VIII, L.P.'s most active year for disposing of shares, totalling 12 transactions. Domain Partners VIII, L.P.'s most active month to dispose stocks was the month of July. 2012 saw Domain Partners VIII, L.P. paying a total of $7,006,824.00 for 3,006,132 shares, this is the most they've acquired in one year. In 2014 Domain Partners VIII, L.P. cashed out on 8,627,034 shares for a total of $595,584.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Dicerna Pharmaceuticals Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +97.92% | 1.72M |
$3.19 |
—
| 3.47M |
Dec 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 11
| |||
Form 4
|
∞
| 1.75M |
—
|
—
| 1.75M |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Bionano Genomics, Inc. (BNGO) Snapshot price: $0.46
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +62.05% | 943.88K |
$5.36 | $1,641,890.46 | 2.46M |
Aug 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GLAUKOS Corp (GKOS) Snapshot price: $129.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 876.08K |
—
|
—
| 876.08K |
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Atara Biotherapeutics, Inc. (ATRA) Snapshot price: $9.1465
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.14M |
$11.00 |
—
| 2.14M |
Oct 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $19.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 761.06K |
—
|
—
| 761.06K |
Mar 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |